Tango Therapeutics, Inc. · NASDAQ:TNGX

Crystal Adam sold 27,000 Tango Therapeutics, Inc. shares (Form 4)

Traded Sep 1, 2026 · Filed Sep 3, 2026

On Sep 1, 2026, Crystal Adam (President, R&D) sold 27,000 Tango Therapeutics, Inc. shares at US$22.37 for US$604K under a trading plan, leaving 115,743 shares. Filed Sep 3, 2026 (Form 4).

Sold
27,000 shares
Price
US$22.37
Value
US$604K
Holding after
115,743 shares
Trading plan
Yes (Made under a plan set in advance)
Role
President, R&D

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 1, 2026Common StockOption exercise27,000US$5.20142,743Direct
Sep 1, 2026Common StockSale27,000US$22.37115,743Direct

Source

View original at SEC

Related